Infertility is a health issue with sociological and psychological implications that affects approximately 50 million couples
worldwide and therefore receives global attention. Among fertility issues, male infertility is diagnosed in about 40% of all
cases and the major causes are poor motility of spermatozoa (asthenospermia), low sperm count (oligospermia), abnormal
sperm morphology (teratospermia) and/or combinations of these, leading to their inability to fertilize an oocyte. Such
problems have been mainly addressed by artificial insemination (AI) and in vitro fertilization (IVF). AI involves introducing
sperms into a woman’s uterus with a medical instrument, but its applicability is limited and its success rate is below 30%. In
contrast, IVF and intracytoplasmic sperm injection can be more effective but implicate more invasive procedures such as
removing oocytes from a woman’s ovaries, fertilize them outside of the body and then transfer the embryos back to the
uterus a few days later. These difficulties demand rethinking of assisted fertilization and the sought after novel approaches
that offer more natural procedures with high success rate. Hence, the objective of this project is to use untethered medical microbots to assist sperm
cells to fertilize an oocyte in living organisms (mice model). The MicroRepro project will bring advances in areas such as
bioimaging, nanomaterials science and fundamental biology, boosting the whole field of medical microbots in the process.